fbq('track','PageView'); The Histamine-Leaning Neurobiome Phenotype — GoodOnes™

Gut-Brain Axis Assessment · Phenotype

The Histamine-Leaning Neurobiome Phenotype

GoodOnes Neurobiome · Phenotype · NEURO 02 Settle · ~25% of people

Measured histamine-production capacity reads high — an inflammatory, reactive tilt.
SUPPRESS histamine

In plain terms

This phenotype is defined by one thing standing out: your gut's measured capacity to produce histamine reads high, while the rest of the panel sits close to range.

Histamine is a normal signaling molecule, but in excess it sets an inflammatory, reactive tone — the flushed, itchy, 'wired' edge, and a nervous system that struggles to downshift.

The move is to suppress the histamine drivers and calm the tilt, rather than pile on more strains that could feed it.

The gut-brain mechanism, in depth

Histamine in the gut comes partly from microbes carrying histidine decarboxylase (hdc), which converts dietary histidine into histamine. When that capacity is elevated, local histamine rises, acting on mast cells and the enteric nerves and raising inflammatory tone along the gut-brain axis.

High histamine tone can amplify visceral sensitivity and reactivity and interact with allergic and hormonal cycles. The formula answer is competitive: crowd out the histamine drivers, deliberately avoid histamine-producing strains, and add a botanical that calms the reactive tilt.

Your measured signature

Measured functional capacity across the 11 gut-brain pathways — read from targeted gene markers in Flore's sequencing data (not inferred from which microbes are present), and CLR-normalized so pathways compare across people. In this phenotype (measured prevalence 24.6%, n = 1,032 of ~4,194 clustered samples) the standout readings are:

Histamine (hdc) ▲ high z = +0.57
Polyamine (speA) ▼ low z = -0.55

z = standard deviations from the cohort mean. These clusters come from the measured capacity alone and are not an artifact of sequencing batch (cluster/run agreement ≈ 0).

Signature chart — measured capacity across the 11 gut-brain pathways

cohort mean (z=0)Butyrate — buk route-0.28Butyrate — but route+0.13Bile-salt hydrolase (bsh)+0.16GABA production (gadB)-0.20Tryptamine — serotonin precursor (tdc)-0.01Indole / tryptophan shunt (tnaA)-0.25Histamine (hdc)+0.57Tyramine (tyrDC)-0.41p-cresol (hpdB)-0.14Polyamine (speA)-0.55Polyamine (speC)+0.15

How common is this phenotype?

Where your pattern sits among the six measured phenotypes:

NEURO 01 Steady26.4%NEURO 02 Settle24.6%NEURO 03 Flow23.6%NEURO 04 Ease14.6%NEURO 05 Cool8.8%NEURO 06 Rebuild2.1%

Does this sound like you?

Framed as tendencies, not a diagnosis:

In the gut: Reactivity to certain foods, looser stools at times, a sense the gut is 'inflamed' or touchy.

In mood & mind: A wired, over-reactive edge; poorer tolerance of stress; symptoms that track hormonal or allergic cycles.

What the data shows

Across our microbiome dataset (n = 1,037 in this phenotype), these self-reported conditions were more common in this pattern than at baseline — associations, not a diagnosis:

Anxiety 56% report it OR 1.03 q = 0.93
Frequent diarrhea 22% report it OR 1.01 q = 1.00
Pre-diabetic 5% report it OR 1.16 q = 0.68

Note: in this phenotype no symptom reached FDR significance — the reports above sit at or near the population base rate. That is the core finding of the analysis: symptoms are orthogonal to phenotype. The same complaint (say, anxiety) spreads across all six phenotypes at close to base rate, so a symptom can’t tell you your biology — only the measurement can.

Top associations (none reached FDR significance in this phenotype — see note above):

OR 1AnxietyOR 1.03Frequent diarrheaOR 1.01Pre-diabeticOR 1.16Severe PMSOR 1.55

What your formula does

The matched formula’s action is SUPPRESS histamine — crowd out the over-driven producers by competitive exclusion and deliberately leave out the carrier strains.

How this formula is designed

Settle is a suppressor formula. The design idea across the NEURObiotic line is to feed the bacteria, not dose you — pair targeted strains with prebiotic fibers and, where a phenotype calls for it, a tiny modulator boost chosen to work with those strains in the gut. It tempers an over-active pathway two ways: by which strains it leaves out, and by a small modulator boost chosen to work with the strains it keeps. As a formulation choice, Settle leaves out histamine-producing Lactobacillus reuteri. Its prebiotics (chia seed and Solnul® resistant potato starch) feed the base strains; the Reishi modulator is a potentiation-level amount — by design, a subclinical potentiator.

Supplement Facts

Supplement Facts

Serving Size: 1 capsule · Servings Per Container: 30

Probiotic Blend
L. plantarum, B. longum, B. bifidum, L. rhamnosus
24 Billion CFU
Neurobiotic prebiotics
Chia seed140 mg
Solnul® resistant potato starch150 mg
Neurobiotic modulators
Reishi (Ganoderma lucidum)10 mg

† Daily Value (DV) not established. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Amounts are pending final raw-material Certificate of Analysis (COA) confirmation — the modulator amounts (Reishi, Lion’s Mane, GABA and Ashwagandha at 10 mg) and the prebiotic splits are proposed.

Take it into your own hands

Your phenotype points to specific, self-directed levers — the “be your own biohacker” angle. None of this is medical treatment; it’s how to feed the pathway the measurement flagged:

  • Build low-histamine awareness: favor fresh over aged, and mind leftovers, aged cheese and fermented foods that concentrate histamine.
  • Support the body's histamine-clearing (DAO) pathway with a nutrient-dense, whole-food pattern.
  • Protect sleep and down-regulate stress — mast-cell reactivity rises when you're run down.
  • Introduce fermented foods cautiously; they help many phenotypes but can provoke this one.

One honest caveat

Your quiz result is a symptom-based pattern, not a verdict — and symptoms are orthogonal to biology, so a measured gut test is what confirms your true phenotype. Everything here is educational and non-therapeutic: formulas potentiate, suppress or support gut-brain pathways; they do not treat, cure or diagnose disease.

Your matched formula

Your result matches the GoodOnes formula built for this gut-brain pattern: Settle. Start there — or confirm your true phenotype first with a measured whole-genome (WGS) test.

See the Settle formula →
Non-therapeutic: potentiate / suppress / support — never treat, cure or diagnose. By GoodOnes™ · Real Good Ones. Capsules or powder, never liquid.

Confirm it with a test

This result is a symptom-based read — a strong starting point, not a verdict. Symptoms and your actual gut biology are only loosely linked, so the one way to know your true phenotype is to measure it. A whole-genome (WGS) microbiome test reads the real gut-brain gene signatures shown above — the same pathways (butyrate, GABA, serotonin, bile acids) — from your own sequencing data, so your formula is built on measured capacity, not a guess.

Measure your neurobiome →

The other neurobiome phenotypes

Not sure which is you? Take the 2-minute Gut-Brain Axis Assessment →